Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Estimation of cognitive impairment in chronic pain patients and characteristics of estimated mild cognitive impairment 2024-03-05
  2. Characteristics of plaque lipid-associated macrophages and their possible roles in the pathogenesis of atherosclerosis 2022-08-03
  3. Characteristics of Neuropsychiatric Mobile Health Trials: Cross-Sectional Analysis of Studies Registered on ClinicalTrials.gov 2020-08-04

Studies

7 studies carry this tag.

Date range

2010 to 2024

Top journals

  • Current opinion in lipidology 1
  • Frontiers in neurology 1
  • JMIR mHealth and uHealth 1
  • Journal of the neurological sciences 1
  • Neuroscience letters 1

7 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Estimation of cognitive impairment in chronic pain patients and characteristics of estimated mild cognitive impairment

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Frontiers in neurology 2024-03-05 Biomarkers

    Patients with chronic pain may exhibit cognitive impairment due to systemic metabolic disturbances.

  2. Characteristics of plaque lipid-associated macrophages and their possible roles in the pathogenesis of atherosclerosis

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Current opinion in lipidology 2022-08-03 TREM2 and immune genetics

    Recent findings from single-cell transcriptomic studies prompted us to revisit the role of plaque foamy macrophages in the pathogenesis of atherosclerosis.

  3. Characteristics of Neuropsychiatric Mobile Health Trials: Cross-Sectional Analysis of Studies Registered on ClinicalTrials.gov

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. JMIR mHealth and uHealth 2020-08-04 Cognitive tests and assessment

    Despite the increasing use of health-based technologies, this analysis of ClinicalTrials.gov suggests that only a few apps for high-burden neuropsychiatric conditions are being clinically evaluated in trials.

  4. Neuropathological and transcriptomic characteristics of the aged brain

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. eLife 2017-11-09 Genetics

    As more people live longer, age-related neurodegenerative diseases are an increasingly important societal health issue.

  5. Behavioral health characteristics of a technology-enabled sample of Alzheimer's caregivers with high caregiver burden

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. mHealth 2017-08-29 Cognitive tests and assessment

    Dementia caregivers with Internet and smartphone access demonstrate high levels of caregiver burden, depression, and anxiety, and are well-suited to receive caregiver support services delivered via mobile devices that target these issues.

  6. The characteristics of camptocormia in patients with Parkinson's disease: A large cross-sectional multicenter study in Japan

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Journal of the neurological sciences 2015-09-08 Biomarkers

    The goal of the present study was to clarify the clinical characteristics and laboratory results of parkinsonian symptoms among patients with and without camptocormia.

  7. Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Neuroscience letters 2010-11-19 Biomarkers

    Familial Alzheimer's disease (AD) due to PSEN1 mutations provides an opportunity to examine AD biomarkers in persons in whom the diagnosis is certain.

All topic tags with their study counts